PALATIN TECHNOLOGIES INC (PTN) Stock Fundamental Analysis
USA - NYSEARCA:PTN - US6960775020 - Common Stock
0.0941 USD
-0.08 (-44.65%)
PTN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. PTN may be in some trouble as it scores bad on both profitability and health. PTN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PTN had negative earnings in the past year.
PTN had a negative operating cash flow in the past year.
In the past 5 years PTN always reported negative net income.
PTN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of PTN (-625.34%) is worse than 97.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -625.34% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of PTN (1255.00%) is better than 100.00% of its industry peers.
PTN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PTN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1255% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
2. Health
2.1 Basic Checks
PTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PTN has more shares outstanding
PTN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PTN has an improved debt to assets ratio.
2.2 Solvency
PTN has an Altman-Z score of -171.53. This is a bad value and indicates that PTN is not financially healthy and even has some risk of bankruptcy.
PTN has a worse Altman-Z score (-171.53) than 98.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -171.53 |
ROIC/WACCN/A
WACC10.35%
2.3 Liquidity
PTN has a Current Ratio of 0.38. This is a bad value and indicates that PTN is not financially healthy enough and could expect problems in meeting its short term obligations.
PTN has a worse Current ratio (0.38) than 94.48% of its industry peers.
A Quick Ratio of 0.38 indicates that PTN may have some problems paying its short term obligations.
With a Quick ratio value of 0.38, PTN is not doing good in the industry: 94.13% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.31% over the past year.
The Revenue for PTN has decreased by -95.07% in the past year. This is quite bad
Measured over the past years, PTN shows a very negative growth in Revenue. The Revenue has been decreasing by -40.52% on average per year.
EPS 1Y (TTM)40.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)-95.07%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%
3.2 Future
PTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.24% yearly.
PTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 162.67% yearly.
EPS Next Y51.7%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PTN. In the last year negative earnings were reported.
PTN is valuated cheaply with a Price/Forward Earnings ratio of 0.14.
99.64% of the companies in the same industry are more expensive than PTN, based on the Price/Forward Earnings ratio.
PTN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.14 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PTN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PTN's earnings are expected to grow with 48.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.7%
EPS Next 3Y48.26%
5. Dividend
5.1 Amount
No dividends for PTN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:PTN (5/7/2025, 8:04:01 PM)
0.0941
-0.08 (-44.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners14.18%
Inst Owner Change-0.05%
Ins Owners0.72%
Ins Owner Change2.24%
Market Cap2.45M
Revenue(TTM)350.00K
Net Income(TTM)-26952300
Analysts80
Price Target7.14 (7487.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48%
Min EPS beat(2)24.29%
Max EPS beat(2)71.71%
EPS beat(4)3
Avg EPS beat(4)25.29%
Min EPS beat(4)-5.65%
Max EPS beat(4)71.71%
EPS beat(8)3
Avg EPS beat(8)-26.04%
EPS beat(12)6
Avg EPS beat(12)-12.52%
EPS beat(16)8
Avg EPS beat(16)-16.16%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-58.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)63.04%
EPS NY rev (1m)0%
EPS NY rev (3m)40.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.14 | ||
| P/S | 6.99 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.54
EYN/A
EPS(NY)0.69
Fwd EY729.86%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.01
BVpS-0.25
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -625.34% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1255% | ||
| FCFM | N/A |
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.53% | ||
| Cap/Sales | 1.4% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z | -171.53 |
F-Score3
WACC10.35%
ROIC/WACCN/A
Cap/Depr(3y)120.27%
Cap/Depr(5y)96.16%
Cap/Sales(3y)9.17%
Cap/Sales(5y)16.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y51.7%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue 1Y (TTM)-95.07%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%
EBIT growth 1Y1.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.15%
OCF growth 3YN/A
OCF growth 5YN/A
PALATIN TECHNOLOGIES INC / PTN FAQ
What is the fundamental rating for PTN stock?
ChartMill assigns a fundamental rating of 2 / 10 to PTN.
Can you provide the valuation status for PALATIN TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 4 / 10 to PALATIN TECHNOLOGIES INC (PTN). This can be considered as Fairly Valued.
Can you provide the profitability details for PALATIN TECHNOLOGIES INC?
PALATIN TECHNOLOGIES INC (PTN) has a profitability rating of 1 / 10.
What is the financial health of PALATIN TECHNOLOGIES INC (PTN) stock?
The financial health rating of PALATIN TECHNOLOGIES INC (PTN) is 0 / 10.